S-3 GROUP

Lobbying for GOODRX · Healthcare company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Pharmacy

Issues regarding lower prescription drug prices for patients

Health Issues

Issues regarding lower prescription drug prices for patients

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.